LaPlume Joseph W's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Feb 23, 2022
- Accession no.
- 0001127602-22-006343
- Filed
- Feb 23, 2022
- Trade date
- Feb 14-23, 2022
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $448.7K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| LaPlume Joseph WCIK 0001767215 | Officer (EVP, Corp Strategy & Develop) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2022 | Common Stock | GGiftDisposed | −150 | $0.00 | $0 | 21,675 | Direct | |
| Feb 18, 2022 | Common Stock | MOption exerciseAcquired | +743 | $88.05 | +$65,421.15 | 22,418 | Direct | |
| Feb 18, 2022 | Common Stock | SSaleDisposed | −1,143 | $291.80F1 | −$333,527.4 | 21,275 | Direct | |
| Feb 22, 2022 | Common Stock | FTax withholdingDisposed | −317 | $293.61 | −$93,074.37 | 20,958 | Direct | |
| Feb 22, 2022 | Common Stock | SSaleDisposed | −4 | $290.81 | −$1,163.24 | 20,954 | Direct | |
| Feb 22, 2022 | Common Stock | SSaleDisposed | −392 | $290.83 | −$114,005.36 | 20,562 | Direct | |
| Feb 23, 2022 | Common Stock | FTax withholdingDisposed | −315 | $289.58 | −$91,217.7 | 20,247 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2022 | Common Stock | MOption exerciseDisposed | −743 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $291.68 to $292.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.